Trial intelligence / Profile preview

FlutiForm versus Seretide in adults with asthma

2006-005926-22Phase 3Completed

Sponsor
Mundipharma Research
Start
Jan 2007
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial in asthma comparing FlutiForm arm with Seretide arm (2 arms). Primary endpoints: Mean forced expiratory volume in 1 second and Safety measured by forced expiratory volume in 1 second. Started Jan 2007; status: completed.

02

Drugs

fluticasone propionate + formoterolsalmeterol + fluticasone
03

Conditions

asthma

Beyond the preview

Go deeper on 2006-005926-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005926-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call